Aim. Desloratadine (DL) is an effective treatment for chronic idiopathic urticaria (CIU) symptoms, but there is little information about its impact on patients' perceived general wellbeing. The primary objective was to measure the effect of DL on the quality of life (QoL) of CIU patients, using the Dermatology Life Quality Index (DLQI). Secondary objectives were: evaluation of the effects of DL on pruritus and number of hives, sleep and daily activities, overall CIU condition, and assessment of therapeutic response. Safety and tolerability of DL were also evaluated. Methods. Two-hundred and fifty-five patients, aged 18-79 years and with moderate to severe CIU, were treated with DL 5 mg once daily for 28 days. Patients recorded signs and sym...
Background: Chronic urticaria is a debilitating disease that considerably affects health-related qua...
Hintergrund und Zielsetzung Kälteurtikaria ist eine mastzellvermittelte Erkrankung, die durch Kältee...
Background Real-world evidence describing the benefits of recommended therapies and their impact on ...
BACKGROUND: Chronic idiopathic urticaria (CIU) is defined by the almost daily presence of urticaria ...
The term ''chronic idiopathic urticaria'' denotes a spectrum of conditions with different poorly und...
The intense pruritus and evanescent skin lesions of urticaria are poorly tolerated by patients, and ...
BACKGROUND: H 1 -receptor antagonists are considered to be particularly effective in reducing prurit...
Background Chronic urticaria (CU) is a common skin condition. It is frequently a disabling disease d...
Background: A Worldwide Antihistamine-Refractory Chronic Urticaria (CU) patient Evaluation (AWARE) i...
Context Desloratadine, an H1 receptor antagonist, is suggested as an effective first-line drug for c...
Chronic urticaria (CU) affects about 1% of the world population of all ages, mostly young and middle...
The Author(s) 2015. This article is published with open access at Springerlink.com Introduction: Chr...
Background : Treatment of chronic idiopathic urticaria (CIU) is challenging because of its unpredict...
Objective: During its first year, the AWARE study assessed disease activity, patient quality of life...
Chronic urticaria (CU) is a skin condition characterized by sudden and recurrent episodes of wheals,...
Background: Chronic urticaria is a debilitating disease that considerably affects health-related qua...
Hintergrund und Zielsetzung Kälteurtikaria ist eine mastzellvermittelte Erkrankung, die durch Kältee...
Background Real-world evidence describing the benefits of recommended therapies and their impact on ...
BACKGROUND: Chronic idiopathic urticaria (CIU) is defined by the almost daily presence of urticaria ...
The term ''chronic idiopathic urticaria'' denotes a spectrum of conditions with different poorly und...
The intense pruritus and evanescent skin lesions of urticaria are poorly tolerated by patients, and ...
BACKGROUND: H 1 -receptor antagonists are considered to be particularly effective in reducing prurit...
Background Chronic urticaria (CU) is a common skin condition. It is frequently a disabling disease d...
Background: A Worldwide Antihistamine-Refractory Chronic Urticaria (CU) patient Evaluation (AWARE) i...
Context Desloratadine, an H1 receptor antagonist, is suggested as an effective first-line drug for c...
Chronic urticaria (CU) affects about 1% of the world population of all ages, mostly young and middle...
The Author(s) 2015. This article is published with open access at Springerlink.com Introduction: Chr...
Background : Treatment of chronic idiopathic urticaria (CIU) is challenging because of its unpredict...
Objective: During its first year, the AWARE study assessed disease activity, patient quality of life...
Chronic urticaria (CU) is a skin condition characterized by sudden and recurrent episodes of wheals,...
Background: Chronic urticaria is a debilitating disease that considerably affects health-related qua...
Hintergrund und Zielsetzung Kälteurtikaria ist eine mastzellvermittelte Erkrankung, die durch Kältee...
Background Real-world evidence describing the benefits of recommended therapies and their impact on ...